ZOM Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	8.53M
Średni wolumen	4.87M
Kapitalizacja rynkowa	142.29M
EPS	$0 ( 2024-03-20 )
Następna data zysków	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.63
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Heaton Larry C Ii	Buy	100 000	Common Stock, without par value
2023-11-15	Powers Johnny D	Buy	150 000	Common Stock, without par value

INSIDER POWER
94.53
Last 93 transactions
Buy: 92 487 495 \| Sell: 14 772 509

Wolumen Korelacja

Długi: 0.31 (neutral)

Krótki: 0.43 (neutral)

Signal:(60.635) Neutral

Zomedica Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zomedica Pharmaceuticals Korelacja - Waluta/Towar

0.00
( neutral )

0.49
( neutral )

Zomedica Pharmaceuticals Finanse

Annual	2024
Przychody:	$25.19M
Zysk brutto:	$17.32M (68.76 %)
EPS:	$-0.0352

FY	2024
Przychody:	$25.19M
Zysk brutto:	$17.32M (68.76 %)
EPS:	$-0.0352

FY	2023
Przychody:	$18.93M
Zysk brutto:	$13.65M (72.12 %)
EPS:	$-0.0174

FY	2022
Przychody:	$4.13M
Zysk brutto:	$3.05M (73.89 %)
EPS:	$-0.0192

Financial Reports:

No articles found.

Zomedica Pharmaceuticals

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Aktualne aktualizacje dla Zomedica Pharmaceuticals [ZOM]

Upcoming Earnings Alert